Contents

Current Medicinal Chemistry, Volume 13 - Number 3

Agonists and Antagonists of Protease Activated Receptors (PARs)

, 13(3): 243 - 265

Grant D. Barry, Giang T. Le and David P. Fairlie


DOI: 10.2174/092986706775476070




Urotensin-II Receptor Antagonists

, 13(3): 267 - 275

A. Carotenuto, P. Grieco, P. Rovero and E. Novellino


DOI: 10.2174/092986706775476061




Prediction Oriented QSAR Modelling of EGFR Inhibition

, 13(3): 277 - 287

C. Szantai-Kis, I. Kovesdi, D. Eros, P. Banhegyi, A. Ullrich, G. Keri and L. Orfi


DOI: 10.2174/092986706775476098




P2 Receptors Activated by Uracil Nucleotides - An Update

, 13(3): 289 - 312

Andreas Brunschweiger and Christa E. Muller


DOI: 10.2174/092986706775476052




HIV-1 Reverse Transcriptase: A Therapeutical Target in the Spotlight

, 13(3): 313 - 324

H. C. Castro, N. I.V. Loureiro, M. Pujol-Luz, A. M.T. Souza, M. G. Albuquerque, D. O. Santos, L. M. Cabral, I. C. Frugulhetti and C. R. Rodrigues


DOI: 10.2174/092986706775476089




Taking Advantage of Viral Immune Evasion: Virus-Derived Proteins Represent Novel Biopharmaceuticals

, 13(3): 325 - 333

L. Amati, M. E. Passeri, A. Lippolis, D. Lio, C. Caruso, E. Jirillo and V. Covelli


DOI: 10.2174/092986706775476106




Progresses in the Field of Drug Design to Combat Tropical Protozoan Parasitic Diseases

, 13(3): 335 - 360

Guadalupe E. G. Linares, Esteban L. Ravaschino and Juan B. Rodriguez


DOI: 10.2174/092986706775476043




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science